References
- Abdalla MMI, Soon SC. Salivary adiponectin concentration in healthy adult males in relation to anthropometric measures and fat distribution. Endocr Regul 51, 185-192, 2017.29232191
- Alberti KG, Genuth S, Bennett P, Buse J, Defronzo R, Hahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167, 2003.10.2337/diacare.26.11.3160
- Aleidi S, Issa A, Bustanji H, Khalil M, Bustanji Y. Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm J 23, 250-256, 2014.
- Al-Azzam SI, Khabour OF, Alzoubi KH, Ghanma MW, Alhasan AY. The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients. J Endocrinol Invest 37, 113-118, 2014.
- An SS, Hanley AJ, Ziegler JT, Brown WM, Haffner SM, Norris JM, Rotter JI, Guo X, Chen YD, Wagenknecht LE, Langefeld CD, Bowden DW, Palmer ND. Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study. Mol Genet Metab 107, 721-728, 2012.
- Bouzid T, Hamel FG, Lim JY. Role of adipokines in controlling insulin signaling pathways in type-2 diabetes and obesity. Current and future perspectives. Int J Diabetes Res 5, 75-85, 2016.
- Cefalu WT. Insulin resistance: cellular and clinical concepts. Exp Biol Med (Maywood) 226, 13-26, 2001.
- Chiodini BD, Specchia C, Gori F, Barlera S, D’Orazio A, Pietri S, Crociati L, Nicolucci A, Franciosi M, Signorini S, Brambilla P, Grazia Franzosi M; GISSI Prevenzione Investigators; SiBioC-GISSI Prevenzione Group. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 4, 223-230, 2010.10.1177/1753944710371483
- Cho J, Kim J, Shin J, Shin J, Yoon K. β‐cell mass in people with type 2 diabetes. J Diabetes Investig 2, 6-17, 2011.
- Chu H, Wang M, Zhong D, Shi D, Ma L, Tong N, Zhang Z. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab Res Rev 29, 532-545, 2013.23653335
- Davis SK, Gebreab SY, Xu R, Riestra P, Khan RJ, Sumner AE, Hickson D, Bidulescu A. Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study. BMC Cardiovasc Disord 15, 13, 2015.
- Eissa A. Investigate the relation between Adiponectin gene variants and cardiovascular comorbidities and diabetes. Int J Health Sci (Qassim) 10, 183-189, 2016.
- Erfanian S, Moradzadeh M, Solhjoo K, Jahromi AS. Data describing the association between rs266729 polymorphism in adiponectin promoter gene and Type 2 Diabetes Mellitus. Data Brief 9, 1138-1140, 2016.
- Eshraghi P, Hedayati M, Daneshpour M, Mirmiran, P, Azizi F. Association of body mass index and Trp64Arg polymorphism of the beta3-adrenoreceptor gene and leptin level in Tehran Lipid and Glucose Study. Br J Biomed Sci 64, 117-120, 2007.10.1080/09674845.2007.11732769
- Flegal KM, Kit BK, Graubard BI. Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol 180, 288-296, 2014.
- Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with Type 2 diabetes: A meta-analysis. Mol Cell Endocrinol 325, 78-83, 2010.
- Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, Legge DG, Quan H, Zhao MM, Ning N, Kang Z, Sun H. Associations between single nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54, 2303-2314, 2011.
- Hasani-Ranjbar S, Amoli M M, Tabatabaei-Malazy O, Rumi Y, Tavakkoly-Bazzaz J, Samimi H, Abbasifarid E. Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetes. J of Diabetes and Metab Dis, 11, 14, 2012.
- Henneman P, Aulchenko YS, Frants RR, Zorkoltseva IV, Zillikens MC, Frolich M, Oostra BA, van Dijk KW, van Duijn CM. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndromerelated traits. Diabetes Care 33, 908-913, 2010.10.2337/dc09-1385
- Hsiao TJ, Lin E. A validation study of adiponectin rs266729 gene variant with Type 2 diabetes, obesity, and metabolic phenotypes in a Taiwanese population. Biochem Genet 54, 830-841, 2016.
- Ismail JM, Hussain MK, Mohammad HJ. Association of adiponectin gene polymorphism rs266729 with adiponectin levels in type 2 diabetic patients with and without CVD. In AL-NAJAF governorate, IRAQ. Int. J. of Adv. Res 4, 1089-1096, 2016.
- Kaftan AN, Hussain MK. Association of adiponectin gene polymorphism rs266729 with type two diabetes mellitus in Iraqi population. A pilot study. Gene 570, 95-99, 2015.
- Khan M. M, Sonkar GK, Alam R, Singh S, Mehrotra S, Sonkar SK. Association of ADIPOQ gene variant rs266729 with circulatory adiponectin levels in patients with type 2 diabetes in North Indian population: A casecontrol study. Biomed Pharmacol J 10, 2017.
- Laumen H, Saningong AD, Heid IM, Hess J, Herder C, Claussnitzer M, Baumert J, Lamina C, Rathmann W, Sedlmeier EM, Klopp N, Thorand B, Wichmann HE, Illig T, Hauner H. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 58, 984-991, 2009.10.2337/db07-164619074982
- Li YY, Yang ZJ, Zhou CW, Wang XM, Qian Y, Xu J, Wang B, Wu J. Adiponectin-11377CG gene polymorphism and type 2 diabetes mellitus in the Chinese population: A meta-analysis of 6425 subjects. PLoS ONE 8, e61153, 2013.
- Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, Kelly ME, Chatterjee Bhowmick D, Murano I, Cohen P, Banks AS, Khandekar MJ, Dietrich A, Flier JS, Cinti S, Bluher M, Danial NN, Berggren PO, Spiegelman BM. Adipsin is an adipokine that improves β cell function in diabetes. Cell 158, 41-53, 2014.
- Masson S, Gori F, Latini R, Milani V, Flyvbjerg A, Frystyk J, Crociati L, Pietri S, Vago T, Barlera S, Maggioni AP, Tognoni G, Tavazzi L, Omland T, Franzosi MG; GISSI-HF Investigators. Adiponectin in chronic heart failure: influence of diabetes and genetic variants. Eur J Clin Invest 41, 1330-1338, 2011.2162377810.1111/j.1365-2362.2011.02548.x
- Mente A, Meyre D, Lanktree MB, Heydarpour M, Davis AD, Miller R, Gerstein H, Hegele RA, Yusuf S, Anand SS; SHARE Investigators; SHARE-AP Investigators. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One 8, e66808, 2013.
- Menzaghi C, Salvemini L, Paroni G, De Bonis C, Mangiacotti D, Fini G, Doria A, Di Paola R, Trischitta V. Circulating HMW adiponectin isoform is heritable and shares a common genetic background with insulin resistance in non diabetic White Caucasians from Italy: evidence from a family-based study. J Intern Med 267, 287-294, 2010.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215, 1988.
- Morandi A, Maffeis C, Lobbens S, Bouatia-Naji N, Heude B, Pinelli L, Meyre D, Froguel P. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity (Silver Spring) 18, 1469-1473, 2010.
- Ogedengbe S, Ezeani IU, Aihanuwa E. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study. Endocr Regul 50, 32-40, 2016.27560635
- Olckers A, Towers GW, van der Merwe A, Schwarz PE, Rheeder P, Schutte AE. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 56, 587-592, 2007.10.1016/j.metabol.2006.10.004
- Ong KL, Li M, Tso AW, Xu A, Cherny SS, Sham PC, Tse HF, Lam TH, Cheung BM, Lam KS; Investigators of the Hong Kong Cardiovascular Risk Factor Prevalence Study. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163, 251-257, 2010.
- Prakash J, Mittal B, Awasthi S, Srivastava N. Association of adiponectin gene polymorphism with adiponectin levels and risk for insulin resistance syndrome. Int J Prev Med 6, 31, 2015.
- Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 532, 253-262, 2013.
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607, 1988.
- Renju VC, Santha K, Sethupathy S, Koshy M, Marichamy G, Sri Kumaran N. Serum adiponectin and fasting insulin levels in patients with type 2 diabetics. J Pharm Sci Res 4, 1844-1847, 2012.
- Sheng T, Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. J Genet Genomics 35, 321-326, 2008.10.1016/S1673-8527(08)60047-818571119
- Siitonen N, Pulkkinen L, Lindstrom J, Kolehmainen M, Eriksson JG, Venojarvi M, Ilanne-Parikka P, Keinanen- Kiukaanniemi S, Tuomilehto J, Uusitupa M. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 12, 5, 2011.2121960210.1186/1471-2350-12-5
- Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem 47, 432-438, 2014.10.1016/j.clinbiochem.2014.02.007
- Ukkola O, Santaniemi M, Rankinen T, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bergman R, Kesaniemi YA, Bouchard C. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 37, 141-150, 2005.
- Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11, 2607-2614, 2002.10.1093/hmg/11.21.2607
- Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol- 3’ kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 51, 1052-1059, 2002.
- Xu X, Wen J, Lu Y, Ji H, Su Y, Zhuang J, Su Y, Liu B, Li H, Xu Y. Impact of age on plasma vaspin concentration in a group of normal Chinese people. J Endocrinol Invest, 40(2):143-151, 2017.10.1007/s40618-016-0533-6
- Yamamoto S, Matsushita Y, Nakagawa T, Hayashi T, Noda M, Mizoue T. Circulating adiponectin levels and risk of type 2 diabetes in the Japanese. Nutr Diabetes 4, e130, 2014.10.1038/nutd.2014.27
- Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51, 2968-2974, 2002.
- Zadjali F, Al-Yahyaee S, Hassan MO, Albarwani S, Bayoumi RA. Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: family-based study. Gene 527, 663-669, 2013.